Propofol vs Sevoflurane in Cardiac Surgery
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
The hypothesis of our study: presence of a relationship between the type of anesthesia and complications after cardiac surgery. The aim is to assess the benefit of using intravenous or inhaled anesthesia on the patients\' stay and its complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2024
CompletedFirst Posted
Study publicly available on registry
December 11, 2024
CompletedStudy Start
First participant enrolled
January 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedDecember 11, 2024
December 1, 2024
3 months
September 27, 2024
December 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
determine the relationship between myocardial protection and type of anesthesia
troponin T dosage
48 hours after the surgery
Secondary Outcomes (5)
Association between the type of anesthesia and the speed of awakening
48 hours after the surgery
Association between the length of stay in intensive care and the type of anesthesia
72 hours after the surgery
Determine a relationship between the type of anesthesia and the hemodynamic profile
48 hours after the surgery
Association between the type of anesthesia and pulmonary complications
72 hours after the surgery
Association between the type of anesthesia and neurological complications
72 hours after the surgery
Study Arms (2)
sedation using propofol
PLACEBO COMPARATORthis group will include all patients who will receive propofol during the cardiac surgery and afterwards in the intensive care unit during the post operative phase
sedation using sevoflurane
ACTIVE COMPARATORthis group will include all patients who will receive sevoflurance druing the cardiac surgery and afterwards in the intensive care unit during the postoperative phase
Interventions
The different complications studied will be for example respiratory, neurologic and cardiac based on several clinical and biological parameters.
The differents complications studied will be for example respiratory, neurologic and cardiac based on severl clinical and biological parameters.
Eligibility Criteria
You may qualify if:
- all patients above 18 yeras old that will undergo a cardiac surgery
You may not qualify if:
- below 18 yeras old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2024
First Posted
December 11, 2024
Study Start
January 4, 2025
Primary Completion
March 31, 2025
Study Completion
May 31, 2025
Last Updated
December 11, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share